Live Quote · NASDAQKLRSHealthcare· Biotechnology

Kalaris Therapeutics Inc

$2.66▼ 6.01%($-0.17)
MKT CAP $58.06MNEXT EARNINGS Nov 11, 2026
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
100
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLRS research report →

Analyst Price Target
$15.50+482.7% vs. today

Range $14 – $17

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-66.87% · this period
$10.98$6.82$2.66Oct 06Apr 08Oct 06
52-Week Range2% of range
Low
$2.51
Current
$2.66
High
$11.88